All News #Library
Biotech
HUYABIO Presents HBI-3000 Results in Acute Atrial Fibrillation
06 Jan 2026 //
PR NEWSWIRE
Hyabio Intl. reports positive results from HBI-3000 trial
24 Apr 2025 //
PR NEWSWIRE
HUYABIO Presents Phase 2 Data on HBI-8000 + Nivolumab in Melanoma
08 Nov 2024 //
PR NEWSWIRE

Market Place
Sourcing Support